| 标题 |
Residual cancer burden and benefit from adjuvant capecitabine in CREATE‑X (JBCRG‑04): a prespecified secondary analysis of a randomised, open‑label, phase 3 trial |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)